miR-633 level was downregulated in SLE CD4+ T cells, contributing to SLE pathogenesis by targeting AKT1 and activating AKT1/mTOR pathway, which is known to play an important role in the activation of T cells 66. Here, AKT1 is linked to systemic lupus erythematosus.